Oy Contral Pharma Ltd, a Finnish Biotech Company, announces a EUR 7,5 million Financing through a Domestic and Swedish F

Oy Contral Pharma Ltd, a Finnish Biotech Company, announces a EUR 7,5 million Financing through a Domestic and Swedish Fund Raising Oy Contral Pharma Ltd, a specialist in dependence disorders, especially in alcohol abuse, announces today the completion of a 7,5 million EUR financing. The institutional investors include EVLI (Mix, Select and Nordic Smaller Companies), Pohjola, Bio Fund Management, Sitra, Aboa Venture, Dreadnought Finance, Thomproperties, and Innoventure from Finland and Svenska Kyrkan (Swedish Church) and Svenska Röda Korset (Swedish Red Cross) from Sweden. The funds will be